Healthcare Services

Hemoglobin A1c (HbA1c) Testing Market Revenue Expected to Reach $3.31 Billion by 2030 with 10.3% CAGR

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Hemoglobin A1c (HbA1c) Testing Market Evolve From 2026 To 2030?

The hemoglobin a1c (hba1c) testing market size has expanded considerably in recent years. Its valuation is anticipated to increase from $2.02 billion in 2025 to $2.24 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.5%. Historically, this expansion has been driven by factors such as the increasing global prevalence of diabetes, a greater embrace of long-term glucose monitoring, the development of diagnostic laboratory infrastructure, enhanced awareness regarding diabetes screening, and the broader integration of hba1c as a diagnostic benchmark.

The hemoglobin a1c (hba1c) testing market is set for substantial expansion in the coming years. It is forecast to grow to $3.31 billion by 2030, achieving a compound annual growth rate (CAGR) of 10.3%. This projected growth can be ascribed to the increasing uptake of home-based diabetes monitoring, rising investments in connected diagnostic devices, the expansion of preventive healthcare initiatives, a growing emphasis on early diabetes detection, and an increasing demand for rapid diagnostic solutions. Significant trends during the forecast period involve the increasing adoption of point-of-care hba1c testing devices, a rising demand for portable and home-use hba1c analyzers, the growing integration of wireless and connected testing solutions, the expansion of high-accuracy laboratory-based hba1c technologies, and an enhanced focus on standardization and diagnostic accuracy.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18632&type=smp

What Major Drivers Are Influencing Demand In The Hemoglobin A1c (HbA1c) Testing Market?

The growing occurrence of diabetes is projected to fuel the advancement of the hemoglobin A1c (HbA1c) testing market in the future. Diabetes refers to a long-term health condition characterized by the body’s inability to effectively manage blood glucose levels, stemming from either inadequate insulin production or insulin resistance. The increase in diabetes diagnoses is linked to factors such as unhealthy eating habits, particularly the significant intake of processed items and sweetened beverages, alongside inactive lifestyles marked by limited physical movement. Furthermore, an older demographic and a genetic predisposition to diabetes heighten the likelihood of developing the condition. Hemoglobin A1c (HbA1c) testing serves to track blood sugar management over an extended period in diabetic patients, by assessing the average glucose concentration over the preceding two to three months. As an illustration, figures released in June 2023 by The Lancet, a UK-headquartered organization known for publishing books and periodic data, indicate that worldwide diabetes cases are expected to climb from 529 million in 2021 to 1.3 billion by 2050. Consequently, the escalating incidence of diabetes will be a primary catalyst for the expansion of the hemoglobin A1c (HbA1c) testing market.

Which Segment Areas Are Covered In The Hemoglobin A1c (HbA1c) Testing Market Analysis?

The hemoglobin a1c (hba1c) testing market covered in this report is segmented –

1) By Testing Method: Laboratory-Based Testing, Point Of Care (PoC) Testing

2) By Product Type: Instruments, Reagents, Kits

3) By Technology: Immunoassays, Chromatography, Enzymatic Assays, Boronate Affinity Chromatography, High Performance Liquid Chromatography

4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Homecare Settings

Subsegments:

1) By Laboratory-Based Testing: High-Performance Liquid Chromatography (HPLC) Testing, Ion-Exchange Chromatography, Capillary Electrophoresis

2) By Point Of Care (PoC) Testing: Fingerstick Testing Devices, Portable Hba1c Analyzers, Handheld Hba1c Test Kits

How Are Trends Impacting The Hemoglobin A1c (HbA1c) Testing Market?

Major companies in the hemoglobin A1c (HbA1c) testing market are focusing on technological advancements within diagnostic testing, such as HbA1c home tests, to deliver more convenient, accurate, and accessible options for early diabetes detection and management. HbA1c home tests are at-home diagnostic kits that allow individuals to measure their average blood sugar levels over the past 2-3 months, aiding in diabetes monitoring and management. For instance, in February 2023, Hurdle Health, a US-based company dedicated to providing innovative healthcare solutions, including diagnostic tools for chronic disease management, launched its Hemoglobin A1c (HbA1c) Test. This new at-home blood sample test enables adults to screen and monitor diabetes, supporting Chronomics’ mission to improve accessibility to diagnostic testing and enhance health outcomes through direct-to-consumer solutions.

Which Global Companies Are Actively Competing In The Hemoglobin A1c (HbA1c) Testing Market?

Major companies operating in the hemoglobin a1c (hba1c) testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Tosoh Corporation, Hitachi High-Technologies Corporation, Beckman Coulter Inc, Sysmex Corporation, Bio Rad Laboratories Inc, ARKRAY Inc, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Agappe Diagnostics Ltd, SEKISUI Diagnostics LLC, Helena Laboratories, Transasia Bio Medicals Ltd, EKF Diagnostics, Trinity Biotech plc, HemoCue AB, CPC Diagnostics Pvt Ltd, PTS Diagnostics, Menarini Diagnostics srl, Diazyme Laboratories Inc, Osang HealthCare Co Ltd, Eurolyser Diagnostica GmbH, DiaSys Diagnostic Systems GmbH

Read the full hemoglobin a1c (hba1c) testing market report here:

https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-hba1c-testing-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Hemoglobin A1c (HbA1c) Testing Market?

North America was the largest region in the hemoglobin A1c (HbA1c) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemoglobin a1c (hba1c) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Hemoglobin A1c (HbA1c) Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18632&type=smp

Browse Through More Reports Similar to the Global Hemoglobin A1c (HbA1c) Testing Market 2026, By The Business Research Company

Hemoglobin A1C Testing Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-testing-devices-global-market-report

Hemoglobin Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/hemoglobin-testing-global-market-report

Poc Hba1C Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/poc-hba1c-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795